If a person signs a negotiable instrument because he is fraudulently deceived regarding its nature or essential terms gives the holder a universal defense
Indicate whether the statement is true or false
True
You might also like to view...
A good ethical decision must reflect the morals and values of the larger organization. This reflects which of the five timeless questions?
A. What are my core obligations? B. What can I live with? C. What will work in the world as it is? D. Who are we?
Gregorich Incorporated makes a single product-a critical part used in commercial airline seats. The company has a standard cost system in which it applies overhead to this product based on the standard machine-hours allowed for the actual output of the period. Data concerning the most recent year appear below: Budgeted fixed manufacturing overhead$294,490 Budgeted production (a) 35,000unitsStandard hours per unit (b) 1.40machine-hoursBudgeted hours (a) × (b) 49,000machine-hours Actual production (a) 30,000unitsStandard hours per unit (b) 1.40machine-hoursStandard hours allowed for the actual production (a) × (b) 42,000machine-hours Actual fixed manufacturing overhead$314,490 Actual hours 40,600machine-hoursThe fixed overhead budget variance is:
A. $62,070 U B. $20,000 F C. $62,070 F D. $20,000 U
A subject line
a. is used only when composing a memo or email message. b. sets the stage for the receiver to understand the message. c. directs a document to a specific person. d. provides a record of how the document was sent.
Roe-Pharma, a Canadian drug company, obtained a licence from Mega-mega-Pharma, a Swiss drug company, to sell Heptamyoextropalol in Canada. Reo-Pharma sells this patented medicine for $15 per pill
Generic Drugs Inc, another Canadian company, says that it can sell this drug for $2.50 per pill. Which of the following is true? A) GDI can apply for a compulsory licence but it will not be granted because Reo-Pharma is using the patent. B) GDI cannot apply for a compulsory licence pursuant to the Patent Law Amendment Act, 1992. C) GDI will likely be granted a compulsory licence under the Patent Act because the price at which this drug is currently being sold is so high. D) The Patented Medicine Price Review Board may reduce the price of Heptamyoextropalol if it feels it is excessive. E) Both B and D